{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:47:39Z","timestamp":1794649659325,"version":"4.9.1"},"reference-count":38,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,6,1]]},"abstract":"<jats:p>Probiotic products in the United States are available for use in the general category of dietary supplements, bypassing the rigor of the US Food and Drug Administration (FDA) approval process in safety, efficacy, and manufacturing standards. As a result, currently available probiotics lack FDA-approved drug labeling and cannot be marketed to treat or prevent disease in preterm infants, including necrotizing enterocolitis and late-onset sepsis. Despite lack of availability of a pharmaceutical-grade product, the number of preterm infants receiving probiotics in the United States and Canada is steadily increasing. According to recent reports from large collaborative databases in the United States, approximately 10% of extremely low gestational age neonates receive a probiotic preparation during their stay in the NICU, with wide variation in practice among units. In sum, more than 10\u2009000 preterm infants have been enrolled in randomized clinical trials of probiotic supplementation worldwide. Methodologic differences among study protocols included different strains and combinations of therapy, masking of trials, and a priori definitions of the primary outcome measure. Large meta-analyses of these trials have demonstrated the efficacy of multiple-strain probiotics in reducing necrotizing enterocolitis and all-cause mortality, whereas the efficacy of single-strain probiotic preparations is less certain. In the absence of an appropriate medical-grade product in the United States, dietary supplement\u2013grade probiotics, some of which have been the subject of recent recalls for contamination, are being prescribed. Given the lack of FDA-regulated pharmaceutical-grade products in the United States, conflicting data on safety and efficacy, and potential for harm in a highly vulnerable population, current evidence does not support the routine, universal administration of probiotics to preterm infants, particularly those with a birth weight of &amp;lt;1000 g.<\/jats:p>","DOI":"10.1542\/peds.2021-051485","type":"journal-article","created":{"date-parts":[[2021,5,24]],"date-time":"2021-05-24T04:25:46Z","timestamp":1621830346000},"source":"Crossref","is-referenced-by-count":169,"title":["Use of Probiotics in Preterm Infants"],"prefix":"10.1542","volume":"147","author":[{"given":"Brenda","family":"Poindexter","sequence":"first","affiliation":[{"name":"Children\u2019s Healthcare of Atlanta and School of Medicine, Emory University, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"COMMITTEE ON FETUS AND NEWBORN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Hand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira","family":"Adams-Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan W.","family":"Aucott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen M.","family":"Puopolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay P.","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilia","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Mowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2021,6,1]]},"reference":[{"issue":"1","key":"2022020222200952700_B1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000454668","article-title":"The \u201cgolden age\u201d of probiotics: a systematic review and meta-analysis of randomized and observational studies in preterm infants","volume":"112","author":"Dermyshi","year":"2017","journal-title":"Neonatology"},{"issue":"12","key":"2022020222200952700_B2","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1038\/jp.2016.144","article-title":"Survey and evidence based review of probiotics used in very low birth weight preterm infants within the United States","volume":"36","author":"Viswanathan","year":"2016","journal-title":"J Perinatol"},{"key":"2022020222200952700_B3","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000358465","article-title":"The developing intestinal microbiome: probiotics and prebiotics","volume":"110","author":"Neu","year":"2014","journal-title":"World Rev Nutr Diet"},{"issue":"6","key":"2022020222200952700_B4","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1016\/j.pcl.2017.08.006","article-title":"Probiotics in newborns and children","volume":"64","author":"Lenfestey","year":"2017","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"2022020222200952700_B5","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40168-017-0248-8","article-title":"Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis","volume":"5","author":"Pammi","year":"2017","journal-title":"Microbiome"},{"issue":"1\u20132","key":"2022020222200952700_B6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/pr.2014.156","article-title":"Bifidobacterium longum subspecies infantis: champion colonizer of the infant gut","volume":"77","author":"Underwood","year":"2015","journal-title":"Pediatr Res"},{"issue":"8","key":"2022020222200952700_B7","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrgastro.2014.66","article-title":"Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic","volume":"11","author":"Hill","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"2022020222200952700_B8","unstructured":"National Institutes of Health, Office of Dietary Supplements. Frequently asked questions. Regulatory information. Available at: https:\/\/ods.od.nih.gov\/Health_Information\/ODS_Frequently_Asked_Questions.aspx#Regulatory. Accessed October 13, 2020"},{"issue":"3","key":"2022020222200952700_B9","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/microorganisms7030083","article-title":"The production and delivery of probiotics: a review of a practical approach","volume":"7","author":"Fenster","year":"2019","journal-title":"Microorganisms"},{"issue":"6","key":"2022020222200952700_B10","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1179\/joc.2010.22.6.373","article-title":"Microbiological evaluation of commercial probiotic products available in the USA in 2009","volume":"22","author":"Drago","year":"2010","journal-title":"J Chemother"},{"issue":"6","key":"2022020222200952700_B11","doi-asserted-by":"crossref","first-page":"e00501","DOI":"10.1128\/mSphere.00501-17","article-title":"Persistence of supplemented Bifidobacterium longum subsp. infantis EVC001 in breastfed infants","volume":"2","author":"Frese","year":"2017","journal-title":"mSphere"},{"issue":"3","key":"2022020222200952700_B12","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/pr.2015.244","article-title":"Validating bifidobacterial species and subspecies identity in commercial probiotic products","volume":"79","author":"Lewis","year":"2016","journal-title":"Pediatr Res"},{"issue":"1","key":"2022020222200952700_B13","first-page":"e25","article-title":"Lactobacillus sepsis and probiotic therapy in newborns: two new cases and literature review","volume":"6","author":"Dani","year":"2016","journal-title":"AJP Rep"},{"issue":"4","key":"2022020222200952700_B14","first-page":"CD005496","article-title":"Probiotics for prevention of necrotizing enterocolitis in preterm infants","author":"AlFaleh","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2022020222200952700_B15","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.jhin.2014.09.006","article-title":"Cross-colonization of infants with probiotic organisms in a neonatal unit","volume":"88","author":"Hickey","year":"2014","journal-title":"J Hosp Infect"},{"issue":"10019","key":"2022020222200952700_B16","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0140-6736(15)01027-2","article-title":"Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial","volume":"387","author":"Costeloe","year":"2016","journal-title":"Lancet"},{"issue":"6","key":"2022020222200952700_B17","first-page":"155","article-title":"Notes from the field: fatal gastrointestinal mucormycosis in a premature infant associated with a contaminated dietary supplement\u2013Connecticut, 2014","volume":"64","author":"Vallabhaneni","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"200","key":"2022020222200952700_B18","first-page":"1","article-title":"Safety of probiotics used to reduce risk and prevent or treat disease","author":"Hempel","year":"2011","journal-title":"Evid Rep Technol Assess (Full Rep)"},{"issue":"7","key":"2022020222200952700_B19","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jama.2018.20798","article-title":"Are probiotics money down the toilet? Or worse?","volume":"321","author":"Abbasi","year":"2019","journal-title":"JAMA"},{"issue":"4","key":"2022020222200952700_B20","doi-asserted-by":"crossref","first-page":"240","DOI":"10.7326\/M18-0343","article-title":"Harms reporting in randomized controlled trials of interventions aimed at modifying microbiota: a systematic review","volume":"169","author":"Bafeta","year":"2018","journal-title":"Ann Intern Med"},{"key":"2022020222200952700_B21","doi-asserted-by":"crossref","first-page":"e2429","DOI":"10.7717\/peerj.2429","article-title":"Prevention of necrotizing enterocolitis with probiotics: a systematic review and meta-analysis","volume":"4","author":"Sawh","year":"2016","journal-title":"PeerJ"},{"issue":"1","key":"2022020222200952700_B22","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1053\/j.sempedsurg.2017.11.008","article-title":"Probiotics and necrotizing enterocolitis","volume":"27","author":"Patel","year":"2018","journal-title":"Semin Pediatr Surg"},{"issue":"2","key":"2022020222200952700_B23","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jpeds.2005.03.054","article-title":"Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates","volume":"147","author":"Bin-Nun","year":"2005","journal-title":"J Pediatr"},{"issue":"2","key":"2022020222200952700_B24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1159\/000063096","article-title":"Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study","volume":"82","author":"Dani","year":"2002","journal-title":"Biol Neonate"},{"issue":"1","key":"2022020222200952700_B25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1542\/peds.2004-1463","article-title":"Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants","volume":"115","author":"Lin","year":"2005","journal-title":"Pediatrics"},{"issue":"6","key":"2022020222200952700_B26","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3945\/ajcn.114.099978","article-title":"To give or not to give probiotics to preterm infants","volume":"100","author":"Szajewska","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"2022020222200952700_B27","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1542\/peds.2013-1339","article-title":"Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial","volume":"132","author":"Jacobs","year":"2013","journal-title":"Pediatrics"},{"issue":"2","key":"2022020222200952700_B28","doi-asserted-by":"crossref","first-page":"e0171579","DOI":"10.1371\/journal.pone.0171579","article-title":"Multiple strains probiotics appear to be the most effective probiotics in the prevention of necrotizing enterocolitis and mortality: an updated meta-analysis","volume":"12","author":"Chang","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"2022020222200952700_B29","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MPG.0000000000001897","article-title":"Probiotics for preterm infants: a strain-specific systematic review and network meta-analysis","volume":"67","author":"van den Akker","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"6","key":"2022020222200952700_B30","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1542\/peds.2010-2548","article-title":"Probiotics and prebiotics in pediatrics","volume":"126","author":"Thomas","year":"2010","journal-title":"Pediatrics"},{"issue":"10","key":"2022020222200952700_B31","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1093\/pch\/17.10.575","article-title":"Using probiotics in the paediatric population","volume":"17","author":"Marchand","year":"2012","journal-title":"Paediatr Child Health"},{"issue":"5","key":"2022020222200952700_B32","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/MPG.0000000000002655","article-title":"Probiotics and preterm infants: a position paper by the European Society for Paediatric Gastroenterology Hepatology and Nutrition Committee on Nutrition and the European Society for Paediatric Gastroenterology Hepatology and Nutrition Working Group for Probiotics and Prebiotics","volume":"70","author":"van den Akker","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2022020222200952700_B33","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1053\/j.gastro.2020.05.059","article-title":"AGA clinical practice guidelines on the role of probiotics in the management of gastrointestinal disorders","volume":"159","author":"Su","year":"2020","journal-title":"Gastroenterology"},{"issue":"4","key":"2022020222200952700_B34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa1403489","article-title":"Causes and timing of death in extremely premature infants from 2000 through 2011","volume":"372","author":"Patel","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"2022020222200952700_B35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/MOP.0000000000000730","article-title":"Arguments against routine administration of probiotics for NEC prevention","volume":"31","author":"Pell","year":"2019","journal-title":"Curr Opin Pediatr"},{"issue":"2","key":"2022020222200952700_B36","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/MOP.0000000000000732","article-title":"Arguments for routine administration of probiotics for NEC prevention","volume":"31","author":"Underwood","year":"2019","journal-title":"Curr Opin Pediatr"},{"issue":"3","key":"2022020222200952700_B37","doi-asserted-by":"crossref","first-page":"e741","DOI":"10.1542\/peds.2010-1949B","article-title":"A cautionary note on instituting probiotics into routine clinical care for premature infants","volume":"126","author":"Garland","year":"2010","journal-title":"Pediatrics"},{"issue":"1","key":"2022020222200952700_B38","doi-asserted-by":"crossref","first-page":"e000176","DOI":"10.1136\/bmjpo-2017-000176","article-title":"Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial","volume":"1","author":"Jacobs","year":"2017","journal-title":"BMJ Paediatr Open"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-051485\/1256608\/peds_2021051485.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2021-051485\/1256608\/peds_2021051485.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T17:20:42Z","timestamp":1643822442000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/147\/6\/e2021051485\/180282\/Use-of-Probiotics-in-Preterm-Infants"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":38,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6,1]]},"published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2021-051485","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,1]]},"article-number":"e2021051485"}}